Paritaprevir/Ombitasvir/Ritonavir/Dasabuvir

· AbbVie

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Paritaprevir/Ombitasvir/Ritonavir/Dasabuvir, covering 2018-05-21 to 2018-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks